Myeloproliferative Neoplasms

David W. Bahler, MD, PhD

Medical Director, Hematopathology
Dr. Bahler is an associate professor of pathology at the University of Utah School of Medicine. He is certified by the American Board of Pathology in clinical pathology, with an added qualification in hematology. Dr. Bahler received his PhD in immunology and his MD from the University of Rochester. His research interests include the role of antigen receptor stimulation in the development of lymphoid malignancies.

Sherrie L. Perkins, MD, PhD

Chief Executive Officer, ARUP Laboratories
Dr. Perkins is the CEO of ARUP Laboratories and a professor of pathology at the University of Utah School of Medicine. Dr. Perkins has been with ARUP and the University of Utah for over 25 years. During this time, she has served in numerous leadership roles, including director of hematopathology, interim department chair, division chief of clinical pathology, director of the ARUP R&D Institute, and, for the past 10 years, member of the ARUP Laboratories' executive management team.

Rodney R. Miles, MD, PhD

Medical Director, Hematologic Flow Cytometry
Dr. Miles is an associate professor of pathology at the University of Utah School of Medicine. He received his MD and a PhD in cell biology from the University of Nebraska and is certified by the American Board of Pathology in anatomic and clinical pathology, with subspecialty certification in hematology. His research interests include biological subtypes of adult and pediatric non-Hodgkin lymphomas. Dr. Miles is a member the American Society of Hematology, the Society for Hematopathology, and the United States and Canadian Academy of Pathology.

Todd Kelley, MD

Medical Director, Molecular Hematopathology
Medical Director, Hematopathology
Co-Scientific Director, NGS and Biocomputing
Dr. Kelley is an associate professor in the Department of Pathology at the University of Utah. He received his MS in immunology and microbiology and his MD from Ohio State University, and completed his residency in anatomic and clinical pathology and fellowship training in hematopathology at the Cleveland Clinic. He is board certified in anatomic and clinical pathology by the American Board of Pathology, with subspecialty certification in hematology. His research interests include the identification of novel diagnostic and prognostic biomarkers in leukemia and lymphoma.

Archana Mishra Agarwal, MD

Medical Director, Hematopathology and Special Genetics
Dr. Agarwal is an associate professor of pathology at the University of Utah School of Medicine. She received her MD at Delhi University in India and was a postdoctoral research scholar at the University of Iowa. She served as a pathology resident, a hematopathology fellow, and a molecular genetics pathology fellow at the University of Utah School of Medicine. Dr. Agarwal is board certified in hematopathology, anatomic pathology, and clinical pathology.